ロード中...
EGFR mutation status in a series of Turkish non-small cell lung cancer patients
Epidermal growth factor receptor (EGFR) mutations are potential markers driving carcinogenesis, and may alter the response to EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer (NSCLC). The frequency of EGFR mutations in patients with NSCLC differs according to sex, smoking...
保存先:
| 出版年: | Biomed Rep |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7271734/ https://ncbi.nlm.nih.gov/pubmed/32509305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2020.1308 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|